QA: Chemours Co in us_medicinal_products/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001627223_2022_Chemours_Co.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001627223, Chemours Co

  xvar xval
0 LiabilitiesNoncurrent 4,561,000,000
1 LiabilitiesCurrent 1,907,000,000
2 remainder_Liabilities 0
3 AssetsCurrent 3,345,000,000
4 AssetsNoncurrent 843,000,000
5 PropertyPlantAndEquipmentNet 3,154,000,000
6 Goodwill 102,000,000
7 remainder_Assets 106,000,000
8 GeneralAndAdministrativeExpense 5,556,000,000
9 ResearchAndDevelopmentExpense 107,000,000
10 remainder_Expenses 259,000,000
11 remainder_Revenues 6,345,000,000
12 remainder_NetIncome 185,000,000
13 remainder_ComprehensiveNetIncome -54,000,000
  yvar yval
0 Liabilities 6,468,000,000
1 Assets 7,550,000,000
2 Expenses 5,922,000,000
3 Revenues 6,345,000,000
4 StockholdersEquity 1,082,000,000
5 NetIncome 608,000,000
6 ComprehensiveNetIncome 581,000,000
7 BaseVar 13,262,000,000
8 EconomicCapitalRatio 0.214

Edgar->Model Mapping

Feature Distribution

Change over Time